Both breast and lung cancer cells overexpressing RASSF1C showed a significant reduction in caspase 3/7 activation, while RASSF1A overexpression enhanced caspase 3/7 activity (Figure 4). This evidence concerns the gene CASP3 and lung carcinoma.